- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04399850
Impact of Hypnosis During Invasive Procedure in Intensive Care Unit (HYPNOICU)
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France
- Hôpital Saint-Louis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aged 18 years and older
- ICU hospitalisation
- Non-sedated patients who need an invasive procedure (Invasive procedures are defined as chest tube (insert or remove), fibroscopy, catheter insert, lumbar punction and bone marrow aspiration)
- Physician experienced in hypnosis available
- written informed consent
- health insurance
Exclusion Criteria:
- sedation and intubation, delirium, end-of-life decision,
- deaf patient,
- patient who does not understand French language,
- pregnancy
- patient under guardianship or curatorship
- lack of health insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients who receive hypnosis
Patients who receive hypnosis during procedure by experiment physician
|
Patients who receive hypnosis
|
|
No Intervention: Control arm
Patient with conventional pain management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain distress
Time Frame: within the before and the first hour after the procedure
|
Pain distress change in the hypnosis group measured before and within the first hour after the procedure. Pain distress will be assessed using Numeric rating scale, which goes from 0 (no pain stress) to 10 (maximum pain stress). |
within the before and the first hour after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: within first hour and first 24 hours after procedure
|
Pain intensity will be assessed using Numeric rating scale, which goes from 0 (no pain) to 10 (maximum pain imaginable).
|
within first hour and first 24 hours after procedure
|
|
Number of adverse events
Time Frame: during procedure
|
during procedure
|
|
|
Length of each painful procedure
Time Frame: up to 3 months
|
up to 3 months
|
|
|
Analgesia dose
Time Frame: within first and 24 hours after procedure
|
The dose of each analgesia treatment received by the patient will be collected.
|
within first and 24 hours after procedure
|
|
Type of analgesia
Time Frame: within first and 24 hours after procedure
|
The type of each analgesia treatment received by the patient will be collected.
|
within first and 24 hours after procedure
|
|
Anxiety
Time Frame: within first and 24 hours after procedure
|
Anxiety within first and 24 hours after procedure will be assessed using Numeric rating scale, which goes from 0 (no anxiety) to 10 (maximum anxiety imaginable).
|
within first and 24 hours after procedure
|
|
Post traumatic stress disorder assessed using Impact of Event Scale Revisited (IES R)
Time Frame: at 3 months
|
The IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events.
Items are rated on a 5-point scale ranging from 0 to 4 .
The IES-R yields a total score (ranging from 0 to 88)
|
at 3 months
|
|
Proportion of patients who had hypnosis transe
Time Frame: during procedure
|
during procedure
|
|
|
Description of the experience of hypnosis
Time Frame: at 3 months
|
Qualitative analysis of the experience of hypnosis will be performed using the semi-structured interview
|
at 3 months
|
|
Hospital Anxiety and Depression (HAD) scale
Time Frame: at 3 months
|
The HAD scale is a self-assessment scale for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic. HAD scale is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). A higher score indicates worse outcome. |
at 3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- APHP191042
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.